Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2019-04-18 23:21 2019-04-17 MSOII N/A Rieder Richard M Other Other BUY $100.00 20,000 $2,000,000 20,000 +100.0%
2019-04-19 02:15 2019-04-17 LAWS Distribution Solutions Group, Inc. KING LUTHER CAPITAL MANAGEMENT CORP 10% owner Wholesale-Machinery, Equipment & Supplies BUY $32.00 37,707 $1,206,624 4,338,956 +0.9%
2019-04-18 23:14 2019-04-16 RCKT ROCKET PHARMACEUTICALS, INC. RTW INVESTMENTS, LP Director, 10% owner Pharmaceutical Preparations BUY $17.50 550,005 $9,625,088 17,057,324 +3.3%
2019-04-17 17:41 2019-04-16 N-A N/A Manulife (International) Ltd 10% owner Other BUY $20.69 1,015,018 $21,000,004 15,310,212 +7.1%
2019-04-17 17:32 2019-04-16 N-A N/A Manufacturers Life Reinsurance Ltd 10% owner Other BUY $20.69 1,508,026 $31,200,006 22,746,600 +7.1%
2019-04-17 23:52 2019-04-15 CHAP N/A Strategic Value Partners, LLC 10% owner Other BUY $5.73 1,092,553 $6,257,160 2,492,832 +78.0%
2019-04-18 00:15 2019-04-16 JPM JPMORGAN CHASE & CO HOBSON MELLODY L Director National Commercial Banks BUY $111.02 18,000 $1,998,443 75,355 +31.4%
2019-04-17 20:24 2019-01-02 CPMD CANNAPHARMARX, INC. Herick Gary J Director, Officer - Chief Financial Officer Pharmaceutical Preparations BUY $2.00 600,000 $1,200,000 600,000 +100.0%
2019-04-18 03:18 2019-04-15 AMRS N/A DOERR L JOHN Director, 10% owner Other BUY $2.87 6,732,369 $19,321,899 14,585,144 +85.7%
2019-04-18 04:18 2019-04-17 KMI KINDER MORGAN, INC. KINDER RICHARD D Director, Officer, 10% owner - Executive Chairman Natural Gas Transmission BUY $19.75 175,000 $3,456,040 239,397,332 +0.1%
2019-04-17 20:55 2019-04-16 KMI KINDER MORGAN, INC. KINDER RICHARD D Director, Officer, 10% owner - Executive Chairman Natural Gas Transmission BUY $19.75 152,639 $3,014,300 239,222,332 +0.1%
2019-04-16 23:39 2019-04-12 FARM FARMER BROTHERS CO Levin Easterly Partners LLC 10% owner Miscellaneous Food Preparations & Kindred Products BUY $19.83 562,573 $11,154,022 2,385,029 +30.9%
2019-04-16 02:35 2019-04-15 PD PagerDuty, Inc. Bessemer Venture Partners VIII L.P. 10% owner Services-Prepackaged Software BUY $24.00 300,000 $7,200,000 8,172,224 +3.8%
2019-04-15 23:31 2019-04-11 SCPH N/A RA CAPITAL MANAGEMENT, LLC 10% owner Other BUY $2.70 389,862 $1,052,627 3,247,005 +13.6%
2019-04-16 00:02 2019-04-15 KMI KINDER MORGAN, INC. KINDER RICHARD D Director, Officer, 10% owner - Executive Chairman Natural Gas Transmission BUY $19.75 175,000 $3,456,250 239,069,693 +0.1%
2019-04-16 02:38 2019-04-12 FIXX Q32 Bio Inc. Flynn James E Director, 10% owner, Other Pharmaceutical Preparations BUY $22.50 533,333 $11,999,993 1,158,333 +85.3%
2019-04-12 22:32 2019-04-10 NHS Neuberger High Yield Strategies Fund Inc. Saba Capital Management, L.P. 10% owner Other BUY $11.63 121,750 $1,416,513 3,766,921 +3.3%
2019-04-12 02:59 2019-04-09 TGE N/A Enagas U.S.A. LLC 10% owner Other BUY $24.48 79,534 $1,947,374 400,592 +24.8%
2019-04-12 02:30 2019-04-09 TGE N/A Blackstone Infrastructure Associates L.P. 10% owner Other BUY $24.49 79,534 $1,947,597 400,592 +24.8%
2019-04-11 23:37 2019-04-09 SYRS Syros Pharmaceuticals Inc. AKKARAJU SRINIVAS Director Pharmaceutical Preparations BUY $7.50 533,332 $3,999,990 1,593,270 +50.3%
2019-04-12 00:04 2018-02-09 HK BATTALION OIL CORP ARES MANAGEMENT LLC Director, 10% owner Crude Petroleum & Natural Gas BUY $6.90 1,113,466 $7,682,915 21,855,288 +5.4%
2019-04-12 02:29 2019-04-09 TGE N/A Blackstone Holdings III L.P. 10% owner Other BUY $24.49 79,534 $1,947,597 400,592 +24.8%
2019-04-12 00:32 2019-04-10 BIF SRH Total Return Fund, Inc. SUSAN L CICIORA TRUST 10% owner Other BUY $10.96 1,365,044 $14,960,882 6,837,719 +24.9%
2019-04-11 23:46 2019-04-10 BIF SRH Total Return Fund, Inc. LOLA BROWN TRUST 1B 10% owner Other BUY $10.96 2,319,048 $25,416,766 16,731,365 +16.1%
2019-04-10 19:56 2018-10-09 ANVV N/A Kasa Ali Director, Officer, 10% owner - CEO/Founder Other BUY $1,738.95 23,373,833 $40,645,933,907 19,753,007 +100.0%
2019-04-10 21:12 2019-04-08 NHS Neuberger High Yield Strategies Fund Inc. Saba Capital Management, L.P. 10% owner Other BUY $11.55 132,636 $1,532,423 3,645,171 +3.8%
2019-04-10 23:13 2019-04-08 CYCN Cyclerion Therapeutics, Inc. SCHULMAN AMY W Director Pharmaceutical Preparations BUY $16.00 626,117 $10,017,872 21,635 +100.0%
2019-04-11 00:10 2019-04-08 NGM N/A Svennilson Peter Director, 10% owner Other BUY $16.00 1,895,000 $30,320,000 2,350,957 +415.6%
2019-04-11 00:04 2019-04-08 NGM N/A COLUMN GROUP L P 10% owner Other BUY $16.00 1,890,000 $30,240,000 15,000 +100.0%
2019-04-11 00:07 2019-04-08 NGM N/A GOEDDEL DAVID V Director, 10% owner Other BUY $16.00 1,875,000 $30,000,000 15,634,091 +13.6%
2019-04-10 23:14 2019-04-08 CYCN Cyclerion Therapeutics, Inc. MCGUIRE TERRANCE Director Pharmaceutical Preparations BUY $16.00 626,117 $10,017,872 21,635 +100.0%
2019-04-10 21:16 2019-04-08 VVR Invesco Senior Income Trust Saba Capital Management, L.P. 10% owner Other BUY $4.28 242,325 $1,037,490 20,120,125 +1.2%
2019-04-10 17:49 2019-04-09 KMI KINDER MORGAN, INC. KINDER RICHARD D Director, Officer, 10% owner - Executive Chairman Natural Gas Transmission BUY $19.74 175,000 $3,454,850 238,894,493 +0.1%
2019-04-10 01:27 2019-04-08 NGM N/A Merck & Co., Inc. 10% owner Other BUY $16.00 4,121,683 $65,946,928 12,955,016 +46.7%
2019-04-08 23:34 2019-04-04 TRWH Bally's Corp Chatham Asset Management, LLC 10% owner Hotels & Motels BUY $31.14 80,100 $2,493,922 5,947,916 +1.4%
2019-04-08 18:29 2019-04-03 NHS Neuberger High Yield Strategies Fund Inc. Saba Capital Management, L.P. 10% owner Other BUY $11.52 94,645 $1,090,433 3,512,535 +2.8%
2019-04-09 00:22 2019-04-08 AVEO N/A Sonsini Peter W. 10% owner Other BUY $1.14 4,347,827 $4,956,523 25,243,865 +20.8%
2019-04-09 00:20 2019-04-08 AVEO N/A Makhzoumi Mohamad 10% owner Other BUY $1.14 4,347,827 $4,956,523 25,243,865 +20.8%
2019-04-09 00:20 2019-04-08 AVEO N/A Florence Anthony A. Jr. 10% owner Other BUY $1.14 4,347,827 $4,956,523 25,243,865 +20.8%
2019-04-09 00:18 2019-04-08 AVEO N/A Growth Equity Opportunities Fund IV, LLC 10% owner Other BUY $1.14 4,347,827 $4,956,523 25,243,865 +20.8%
2019-04-09 00:19 2019-04-08 AVEO N/A BASKETT FOREST 10% owner Other BUY $1.14 4,347,827 $4,956,523 25,243,865 +20.8%
2019-04-09 00:21 2019-04-08 AVEO N/A SANDELL SCOTT D 10% owner Other BUY $1.14 4,347,827 $4,956,523 25,243,865 +20.8%
2019-04-09 00:20 2019-04-08 AVEO N/A MAKOWER JOSHUA 10% owner Other BUY $1.14 4,347,827 $4,956,523 25,243,865 +20.8%
2019-04-09 00:21 2019-04-08 AVEO N/A MOTT DAVID M 10% owner Other BUY $1.14 4,347,827 $4,956,523 25,243,865 +20.8%
2019-04-08 18:32 2019-04-03 VVR Invesco Senior Income Trust Saba Capital Management, L.P. 10% owner Other BUY $4.28 1,050,449 $4,499,178 19,877,800 +5.6%
2019-04-09 00:19 2019-04-08 AVEO N/A BARRIS PETER J 10% owner Other BUY $1.14 4,347,827 $4,956,523 25,243,865 +20.8%
2019-04-05 22:26 2019-04-03 TCDA N/A Bonita David P Director, 10% owner Other BUY $36.00 225,000 $8,100,000 11,114,280 +2.1%
2019-04-05 23:06 2019-04-03 CTXR Citius Pharmaceuticals, Inc. Mazur Leonard L Director, Officer, 10% owner - Executive Chairman Pharmaceutical Preparations BUY $1.55 1,165,048 $1,799,999 8,020,643 +17.0%
2019-04-06 00:08 2019-04-03 REV N/A PERELMAN RONALD O Director, 10% owner Other BUY $21.10 65,000 $1,371,663 46,033,321 +0.1%
2019-04-05 22:24 2019-04-03 TCDA N/A ORBIMED ADVISORS LLC Director, 10% owner Other BUY $36.00 225,000 $8,100,000 11,114,280 +2.1%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.